Innopsys, Inc.

Chicago, IL Innopsys Inc.

UEI
ZHBNA5DU8K27
CAGE
73PL7
Primary NAICS
334516 Analytical Laboratory Instrument Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
233 S Wacker Dr Suite 4400, Chicago, IL 60606, USA
Website
innopsys.com
Founded
1999
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Life Sciences Tools & Services
SIC code
38 Instruments & Related Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Innopsys, Inc.'s 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Scanner innoscan 710 autoloader Contract · 1232SA25P0236 Central Program Planning Coordination and Support $85,108
Extended warranty maintenance Contract · 75D30125P20455 CDC Pittsburgh $9,894
Biomedical equipment Contract · 75D30123P17232 CDC Pittsburgh $51,391
For covid-19 research, warranty extension for one year for innoscan 1100 AL, s/n 1120035. POP 8/1/22-7/30/23 QTY 1 @… Contract · 75N93022P00926 National Institute of Allergy and Infectious Diseases $14,700
Covid 19 researcher service contract: innoscan 1100 AL warranty extension for SN 1120035 Contract · 75N93021P01056 National Institute of Allergy and Infectious Diseases $14,700

About Innopsys, Inc.

Innopsys, Inc. is a for-profit corporate entity based in Chicago, Illinois, specializing in biomedical imaging equipment and software solutions. The company is registered in SAM.gov and focuses on providing advanced scientific and research instrumentation, particularly in the life sciences sector. Their primary product line appears to center around high-precision scanning systems like the InnoScan series, which are used in research laboratories and scientific institutions for advanced imaging and analysis.

The federal contract awards reveal that Innopsys, Inc. predominantly serves federal research agencies through purchase order contracts, with significant engagement from the Centers for Disease Control and Prevention (CDC), National Institute of Allergy and Infectious Diseases, and the U.S. Department of Agriculture's Agricultural Research Service. Their contract awards, ranging from $9,894 to $85,108, have involved providing specialized laboratory equipment such as fluorescence confocal scanners, microarray scanner systems, and related warranties and maintenance services. Many of these contracts were awarded under small business set-aside designations, and several were specifically tied to COVID-19 research initiatives. The company's equipment has supported critical research programs, with contracts focused on delivering InnoScan 710 AutoLoader systems, extending equipment warranties, and supplying biomedical research instrumentation to support public health and scientific research efforts.

Quick answers

What is Innopsys, Inc.'s UEI?

Innopsys, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZHBNA5DU8K27.

What is Innopsys, Inc.'s CAGE code?

Innopsys, Inc.'s CAGE code is 73PL7.

What is Innopsys, Inc.'s primary NAICS code?

Innopsys, Inc.'s primary NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing).

Where is Innopsys, Inc. located?

Innopsys, Inc.'s physical address in SAM.gov is 233 S Wacker Dr Suite 4400, Chicago, IL 60606, USA.

Is Innopsys, Inc. registered in SAM.gov?

Yes. Innopsys, Inc.'s SAM.gov registration is active through October 24, 2026.

What is Innopsys, Inc.'s most recent federal award?

Innopsys, Inc.'s most recent federal contract award is Scanner innoscan 710 autoloader (1232SA25P0236), from Central Program Planning Coordination and Support, on September 18, 2025.

On GovTribe

See Innopsys, Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors